News Category
Wellness Eternal's October 2026 Wellness Index Report profiles three experts on brain-driven aging, clinician-controlled precision health AI and infra...
Sequencio Therapeutics, a CK Life Sciences subsidiary, will present preclinical data at SITC 2026 showing its TROP2 and PD-L1/PRAME cancer vaccines ge...
Quantum BioPharma's unbuzzd supplement, designed to support alcohol metabolism, received positive early coverage from Men's Fitness based on a placebo...
Kairos Pharma's ENV-105 showed a statistically significant improvement in progression-free survival for metastatic castration-resistant prostate cance...
Adaptogenics Health Corp. is building its peptide strategy around supply reliability, documented traceability, and independent verification as regulat...
Quantum BioPharma's unbuzzd supplement drink, designed to support alcohol metabolism, has been highlighted by Men's Fitness after a small clinical tri...
ABVC BioPharma raised $3.39 million through a private placement of original issue discount senior convertible notes, with proceeds earmarked for worki...
Tonix Pharmaceuticals names George Lederman, Ph.D., as EVP of Strategy and Transformation to lead AI initiatives and business development, a move that...
Okogen has dosed the first patient in its Phase 1/2 EMERALD Trial evaluating Treyegen for acute infectious conjunctivitis, marking a key clinical mile...
Catherine Cifuentes-Rojas, a director at Ginkgo Bioworks, has published a free checklist to help discovery teams make better early-stage decisions and...
VERAXA Biotech is expanding its use of New Approach Methodologies to improve the clinical relevance of preclinical testing for its antibody-based canc...
Quantum BioPharma has partnered with Thermo Fisher Scientific's clinical research business to advance its Phase 2 trial of Lucid-MS, a novel myelin-pr...
A dual-targeting antibody demonstrated efficacy against multiple tumor types in preclinical research, offering a potential new strategy to expand the ...
Regentis Biomaterials is advancing its GelrinC hydrogel implant for knee cartilage repair, with promising clinical data and regulatory progress in Eur...
Annovis Bio CEO Maria Maccecchini will present at U.S. Biotech Day 2026 and Pharma Partnering Summit 2026, highlighting the company's clinical program...
Oncotelic Therapeutics is advancing its PDAOAI drug discovery engine by leveraging its Partitioned Literature Aggregation algorithm, which identified ...
TransCode Therapeutics has initiated a formal strategic review to evaluate options for maximizing value, including potential asset sales, partnerships...
Certified-PEP's 2026 comparison of 10 research peptide suppliers reveals significant differences in documentation transparency, testing disclosure, an...
Enodia Therapeutics has appointed Henrik Torp Nielsen as Chief Financial Officer to lead its financial strategy as the company advances its proprietar...
A Phase 3 study of 563 patients found that combining two immunotherapy drugs significantly extended survival in a deadly form of lung cancer, offering...
VolitionRx has signed a nonbinding LOI with Missionpharma to explore global development and commercialization of its lateral flow NETosis test, initia...
Creative Biolabs is promoting its complement functional assays and microfluidic droplet generation chip to help researchers address assay variability ...
NanoViricides reports progress in its Phase IIA trial of NV-387 Oral Gummies for Ebola Bundibugyo, a disease with no approved treatments amid a worsen...
A mutated flu version is causing an earlier-than-expected flu season on the West Coast, prompting urgent vaccination drives and highlighting the role ...
Tonix Pharmaceuticals presented Phase 3 data at the IASP 2026 World Congress showing TONMYA significantly improved fibromyalgia symptoms and physical ...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group and replaced five board members with three lender-nominated...
Creative Biolabs is promoting its tumor organoid and immune cell co-culture services, including CAR-T models, to provide more physiologically relevant...
Creative Biolabs has introduced an integrated OMV and exosome-boosted CAR-T development platform to help researchers address the major obstacles limit...
GeoVax Labs has entered a $1 million revolving loan agreement with Bowery Consulting Group, leading to a major board restructuring that gives the lend...
TransCode Therapeutics announced that its Phase 1a trial of TTX-MC138 met its primary safety endpoint with no dose-limiting toxicities and showed dise...
Oncotelic Therapeutics announced a peer-reviewed study showing its PDAOAI platform identified a four-gene prognostic signature in hepatocellular carci...
Tonix Pharmaceuticals will report third-quarter 2026 financial results on Nov. 9, 2026, offering investors a key update on its commercial-stage CNS an...
Coherence Neuro has secured $45 million in Series A funding to develop a brain implant that uses electrical signals to disrupt tumor growth, starting ...
Adaptogenics Health Corp. is advancing a three-part business model combining peptide supply, proprietary therapeutics, and drug delivery technologies ...
Neovii Pharmaceuticals is advancing its FDA Fast Track-designated ATLG program into a pivotal Phase 2 study for Type 1 Diabetes and has named physicia...
Annovis Bio (NYSE: ANVS) will deliver three presentations at the 2026 Clinical Trials on Alzheimer's Disease conference, highlighting its oral therapy...
NeuroThera Labs has completed manufacturing and obtained European batch release certification for its SCI-110 investigational drug, enabling shipment ...
VERAXA Biotech is implementing FDA-aligned New Approach Methodologies across its preclinical research to improve clinical relevance and reduce animal ...
VERAXA Biotech is advancing its BiTAC platform to develop antibody-based cancer therapies that may improve treatment selectivity and reduce toxicity, ...
A new scorecard from the Special Competitive Studies Project shows the United States still leads China in biotechnology but is losing ground in indust...
SS Innovations International launched Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using its SSi Mantra 3.0 system, mar...
Regentis Biomaterials is scaling production of its GelrinC cartilage implant after European approval of a solvent-free process that increases yield by...
Quantum BioPharma's Unbuzzd alcohol recovery formulation was featured in a Men's Fitness article that highlighted promising but limited clinical trial...
Scinai Immunotherapeutics has announced a more than 300% increase in committed CDMO orders to $8.1 million, secured $5.3 million in net financing, and...
Bangladesh's massive measles outbreak, with over 200,000 suspected cases, highlights the global risk of falling vaccination rates and offers lessons f...
NanoViricides announced positive juvenile mouse study results for its antiviral drug NV-387, supporting potential pediatric clinical trials, while als...
VERAXA Biotech is expanding its use of New Approach Methodologies to generate more clinically informative preclinical data while reducing animal testi...
Pentixapharm presented new international data at EANM 2026 supporting Pentixafor PET as a non-invasive alternative to adrenal vein sampling for subtyp...
